Progressive Multifocal Leukoencephalopathy Following Treatment With Obinutuzumab in a Patient With Non-Hodgkin Follicular Lymphoma: A Case Report

Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):e601-e605. doi: 10.1016/j.clml.2021.02.016. Epub 2021 Mar 4.
No abstract available

Keywords: Anti-CD20(+) era; First report; JC polyoma virus; Novel treatments; Relapsing.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Brain / diagnostic imaging
  • Brain / pathology
  • DNA, Viral / isolation & purification
  • Fatal Outcome
  • Female
  • Humans
  • Immunocompromised Host
  • JC Virus / genetics
  • JC Virus / immunology
  • JC Virus / isolation & purification
  • Leukoencephalopathy, Progressive Multifocal / blood
  • Leukoencephalopathy, Progressive Multifocal / chemically induced
  • Leukoencephalopathy, Progressive Multifocal / diagnosis*
  • Leukoencephalopathy, Progressive Multifocal / immunology
  • Lymphoma, Follicular / drug therapy*
  • Lymphoma, Follicular / immunology
  • Magnetic Resonance Imaging
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / immunology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • DNA, Viral
  • obinutuzumab